Peregrine Pharmaceuticals reported 0.01 in EPS Earnings Per Share for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Eps Change
Agenus AGEN:US -0.17 0.02
Amgen AMGN:US $ 4.65 0.4
AstraZeneca AZN:LN 1.72 0.17
Biocryst Pharmaceuticals BCRX:US -0.32 0.08
Bristol Myers Squibb BMY:US $ 1.93 0.13
Celldex Therapeutics CLDX:US -0.59 0.1
Chemocentryx CCXI:US -0.44 0.11
Eli Lilly And LLY:US $ 1.25 1.52
GlaxoSmithKline GSK:LN 0.35 0.02
Immunogen IMGN:US -0.24 0.14
Intrexon XON:US $ -0.09 0.01
Karyopharm Therapeutics KPTI:US -0.62 0.09
Macrogenics MGNX:US -0.67 0.41
Mannkind MNKD:US $ -0.11 0.01
Merk MRK:US $ 1.87 0.27
Minerva Neurosciences NERV:US $ -1.63 0.21
Newlink Genetics NLNK:US -0.92 0.25
Novartis NOVN:VX SF 1.56 0.1
Novavax NVAX:US $ -6.53 9.09
Peregrine Pharmaceuticals PPHM:US 0.01 0.03
Repligen RGEN:US 0.91 0.01
Xencor XNCR:US $ -0.57 0.96